The Lancet Respiratory Medicine: December 05, 2013

enDecember 05, 2013

The Lancet Respiratory Medicine in conversation with

What was the main topic of the podcast episode?

Summarise the key points discussed in the episode?

Were there any notable quotes or insights from the speakers?

Which popular books were mentioned in this episode?

Were there any points particularly controversial or thought-provoking discussed in the episode?

Were any current events or trending topics addressed in the episode?

What was the main topic of the podcast episode?

Summarise the key points discussed in the episode?

Were there any notable quotes or insights from the speakers?

Which popular books were mentioned in this episode?

Were there any points particularly controversial or thought-provoking discussed in the episode?

Were any current events or trending topics addressed in the episode?

About this Episode

Klaus Rabe discusses a study that looks at ADRB2 polymorphisms and drug efficacy in preventing COPD exacerbations in patients from the POET trial.

Continue this conversation on social!
Follow us today at...
https://twitter.com/thelancet
https://instagram.com/thelancetgroup
https://facebook.com/thelancetmedicaljournal
https://linkedIn.com/company/the-lancet
https://youtube.com/thelancettv

Recent Episodes from The Lancet Respiratory Medicine in conversation with

Daniel Steinfort and Shankar Siva on radiotherapy field planning in patients with NSCLC

Professor Daniel Steinfort and Professor Shankar Siva discuss the effect of systematic endoscopic mediastinal staging on radiotherapy field planning in patients with locally advanced non-small-cell lung cancer.

The Lancet Respiratory Medicine in conversation with

enMarch 12, 2024

Daniel Prieto-Alhambra, Annika Jödicke, and Martí Català on vaccination to prevent Long COVID

Prof Daniel Prieto-Alhambra, Dr Annika Jödicke, and Dr Martí Català discuss the effectiveness of COVID-19 vaccines to prevent Long COVID, estimated to affect up to 20% of those infected with SARS-CoV-2.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00414-9/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

The Lancet Respiratory Medicine in conversation with

enJanuary 16, 2024

Sarah Gorst and Tim Nicholson on long COVID outcomes

Dr Tim Nicholson and Dr Sarah Gorst discuss the development of an international Delphi consensus study on a core outcome measurement set for long COVID and how it will be used to inform future research and clinical care.

The Lancet Respiratory Medicine in conversation with

enNovember 02, 2023

Betty Raman on multiorgan MRI abnormalities after hospitalisation with COVID-19

Dr Betty Raman discusses multiorgan MRI findings in patients after hospitalisation with COVID-19.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00262-X/fulltext?dgcid=buzzsprout_icw_podcast_generic_lanres

The Lancet Respiratory Medicine in conversation with

enOctober 04, 2023

Keith Chappell on a bivalent recombinant vaccine for COVID-19

Dr Keith Chappell discusses the bivalent recombinant vaccine for COVID-19 following the study by Dayan and colleagues, with focus on vaccine access, variants and boosters, tolerability and side effects, as well as hopes for future trials.

The Lancet Respiratory Medicine in conversation with

enSeptember 13, 2023

James Chalmers on bronchiectasis across Europe

Prof. James Chalmers discusses the characteristics of patients with bronchiectasis across Europe, the differences between countries, and possible differences in clinical outcomes, based on data from the EMBARC registry.

Read the full article:
https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(23)00093-0/fulltext?dgcid=buzzsprout_tlv_episode-notes_general_general

The Lancet Respiratory Medicine in conversation with

enApril 26, 2023

Richard Costello on management of uncontrolled asthma

Prof Richard Costello discusses the use of digital measurements of medication adherence and lung function to guide management of uncontrolled asthma.

The Lancet Respiratory Medicine in conversation with

enMarch 21, 2023

Keiju Aokage on segmentectomy for ground-glass-dominant lung cancer

Dr Keiju Aokage discusses segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less.

Read the full article:
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial

The Lancet Respiratory Medicine in conversation with

enMarch 06, 2023

Carol Hodgson on post-discharge outcomes for ECMO patients

Carol Hodgson discusses recent advances in our understanding of in-hospital and post-discharge outcomes in critically ill patients who receive ECMO.

Read the full article:
Comparative outcomes of extracorporeal membrane oxygenation for COVID-19 delivered in experienced European centres during successive SARS-CoV-2 variant outbreaks (ECMO-SURGES)

The Lancet Respiratory Medicine in conversation with

enFebruary 09, 2023

Emma Grainger on 10 years of The Lancet Respiratory Medicine

Emma Grainger, Editor-in-Chief of The Lancet Respiratory Medicine, discusses the January issue and plans to celebrate the 10-year anniversary of the journal.

Read the Editorial from the 10th anniversary issue:
Past learnings and new beginnings in the digital age

The Lancet Respiratory Medicine in conversation with

enDecember 22, 2022

Ask this episode Anything

What was the main topic of the podcast episode?

Summarise the key points discussed in the episode?

Were there any notable quotes or insights from the speakers?

Which popular books were mentioned in this episode?

Were there any points particularly controversial or thought-provoking discussed in the episode?

Were any current events or trending topics addressed in the episode?